Betta Pharmaceuticals Co., Ltd.

This study tests two drugs, MCLA-129 and ensartinib, together in people with advanced solid tumors that cannot be cured by standard treatments. The goal is to see if the combination is safe and can shrink or control tumors. About 164 adults aged 18-75 with certain cancers like lu…

This study tests a two-step treatment for people with advanced non-small cell lung cancer whose current targeted therapy (a third-generation EGFR TKI) has stopped working. Participants first receive chemotherapy (pemetrexed plus platinum) followed by a newer targeted drug called …

This study tests an experimental drug called MCLA-129 in people with advanced solid tumors, including lung, head and neck, and colorectal cancers that have stopped responding to standard treatments. The drug is a bispecific antibody designed to target two cancer-related proteins …